Diagnostic and Interventional Cardiology

Judy Hung, M.D., speaking with DAIC Editor Dave Fornell during a video interview at the 2019 American Society of Echocardiography (ASE) annual meeting. Hung took over as ASE President in June.

Judy Hung Elected President of the American Society of Echocardiography

July 8, 2020 – Judy W. Hung, M.D., FASE, took the helm as president of the American Society of Echocardiography (ASE) in ...

July 09, 2020

News | Heart Failure

Novel Hydrogel May Help Repair Cardiac Tissue

July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel ...

July 09, 2020

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business

Philips and Leeds Teaching Hospitals NHS Trust Partner on New Standards For Integrated Cardiac Care

July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service ...

July 08, 2020

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

News | Coronavirus (COVID-19) | Dave Fornell, Editor

American Heart Association Denounces Threats to Public Health Leaders Responding to the COVID-19 Pandemic

July 7, 2020 — In the face of the coronavirus pandemic, public health officials worldwide are working tirelessly to slow ...

July 07, 2020

MedAlliance announced enrollment of the first patient in its study of Selution SLR 0.014 drug-eluting balloon (DEB) for the treatment of in-stent restenosis (ISR). This is the first DEB accepted by the FDA for its breakthrough program. The Selution SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting stent (DES).

News | Drug-Eluting Balloons

World’s First FDA IDE Coronary Patient Treated With a Drug-eluting Balloon

July 7, 2020 – MedAlliance announced enrollment of the first patient in its study of Selution SLR 0.014 drug-eluting ...

July 07, 2020

The Medis QFR technology allows non-invasive functional FFR assessment of coronary flow based on standard X-ray angiographic images in the cath lab without the use of a pressure wire.

Feature | FFR Technologies | Dave Fornell, Editor

Novel FFR Methods Can Reduce Procedure Time and Cost

Fractional flow reserve (FFR) pressure wires have been used now in interventional cardiology procedures for more than a ...

July 07, 2020

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

News | Implantable Cardiac Monitor (ICM)

Next Generation Medtronic ICM Offers Remote Programming and Improved Longevity

July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark ...

July 07, 2020

Canon displays new CT technologies in its virtual SCCT 2020 booth.

News | CT Angiography (CTA)

Canon Showcases Cardiac CT Offerings Virtually at SCCT 2020

Canon Medical Systems USA has created a virtual trade-show experience for its cardiovascular computed tomography (CT) ...

July 06, 2020

News | Cath Lab

Blacks Have Higher Mortality After PCI

July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major ...

July 06, 2020

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Three of the most popular cardiovascular technologies to make news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made s

Feature

July 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

July 06, 2020

The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach

News | Cardiovascular Clinical Studies

Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder

July 1, 2020 — Carag AG announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption ...

July 01, 2020

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Feature | Coronavirus (COVID-19)

New Study Looks at Post-COVID-19 Emerging Disease in Children

In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure or ...

June 30, 2020

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

DiA’s new AI-based LVivo RV enables rapid assessment of right ventricle dysfunction in COVID-19 patients, while LVivo Bladder supports clinicians with automated bladder volume analysis to minimize scan time and risk of infection

News | Artificial Intelligence

DiA Granted FDA Approvals for New COVID-19-related AI Solutions

June 30, 2020 — DiA Imaging Analysis, a leading provider of advanced AI-based solutions for ultrasound analysis ...

June 30, 2020

Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, at work in his laboratory. Photo by Cedars-Sinai.

News | Coronavirus (COVID-19)

COVID-19: Study Shows Virus Can Infect Heart Cells in Lab Dish

June 30, 2020 — A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells ...

June 30, 2020

BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era

News | Heart Failure

BioCardia Resumes Cases in the CardiAMP Heart Failure Trial

June 30, 2020 — BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The ...

June 30, 2020